Reduced TNF-α and IL-1β production in human RA synovial fibroblasts by inhibiting PI3K/AKT, ERK, and NF-κB pathways and enhancing miR-3150a-3p expression. This evidence concerns the gene IL1B and rheumatoid arthritis.